Antimicrobial Therapy for ICU-Acquired Infection: Time for a Reappraisal

  • J. C. Marshall
  • D. C. Evans
Conference paper
Part of the Yearbook of Intensive Care and Emergency Medicine book series (YEARBOOK, volume 1998)

Abstract

Infections acquired in the intensive care unit (ICU) commonly complicate the course of critical illness. Approximately one fourth to one third of patients admitted to an ICU develop one or more episodes of nosocomial infection [1]; both mortality and morbidity are sharply elevated in this population [2] (Table 1). Yet the extent to which such infections are the cause of excess morbidity and mortality, rather than an additional manifestation of organ dysfunction in a subset of the sickest of critically ill patients, is unclear. Equally, although antibiotics are among the most prescribed pharmaceutical agents in contemporary ICUs, it is not at all established that their widespread use in the management of suspected or proven ICU-acquired infection results in net clinical benefit. Indeed there are reasons to suspect that the opposite may be true. A recent analysis of nosocomial infection following cardiac surgery found that the administration of empiric post-operative antibiotics was an independent risk factor for the development of subsequent nosocomial infection [3].

Keywords

Placebo Catheter Carbohydrate Pneumonia Bacillus 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Nathens AB, Chu PTY, Marshall JC (1992) Nosocomial infection in the surgical intensive care unit. Infect Dis Clin North Am 6: 657–675PubMedGoogle Scholar
  2. 2.
    Marshall JC, Sweeney D (1990) Microbial infection and the septic response in critical surgical illness. Sepsis, not infection, determines outcome. Arch Surg 125: 17–23PubMedCrossRefGoogle Scholar
  3. 3.
    Kollef MH, Sharpless L, Vlasnik J, Pasque C, Murphy D, Fraser VJ (1997) The impact of nosocomial infections on patient outcomes following cardiac surgery. Chest 112: 666–675PubMedCrossRefGoogle Scholar
  4. 4.
    Jacobs P, Noseworthy TW (1990) National estimates of intensive care utilization and costs: Canada and the United States. Crit Care Med 18: 1282–1286PubMedCrossRefGoogle Scholar
  5. 5.
    Barza M (1996) Transmission of antibiotic-resistant bacteria in the ICU. New Horizons 4: 333–337PubMedGoogle Scholar
  6. 6.
    Archibald L, Phillips L, Monnet D, McGowan JE, Tenover F, Gaynes R (1997) Antimicrobial resistance in isolates from inpatients and outpatients in the United States: Increasing importance of the intensive care unit. Clin Infect Dis 24: 211–215PubMedCrossRefGoogle Scholar
  7. 7.
    Centers for Disease Control (1993) Nosocomial enterococci resistant to vancomycin — United States — 1989–1993. MMWR 42: 597–599Google Scholar
  8. 8.
    Chow JW, Fine MJ, Shlaes DM, et al (1991) Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 115: 585–590PubMedGoogle Scholar
  9. 9.
    Sanders CC, Sanders Jr WE (1985) Microbial resistance to newer generation B-lactam antibiotics: Clinical and laboratory implications. J Infect Dis 151: 399–406PubMedCrossRefGoogle Scholar
  10. 10.
    Berkelman RL, Hughs JM (1993) The conquest of infectious diseases: who are we kidding? Ann Intern Med 119: 426–428PubMedGoogle Scholar
  11. 11.
    Lee A (1985) Neglected niches. The microbial ecology of the gastrointestinal tract. Adv Microbial Ecol 8: 115–162Google Scholar
  12. 12.
    Van Der Waaij D, Berghuis De Vries JM, Lekkerkerk Van Der Wees JEC (1971) Colonization resistance of the digestive tract in conventional and antibiotic treated mice. J Hyg Camb 69: 405–411Google Scholar
  13. 13.
    Van Der Waaij D (1989) The ecology of the human intestine and its consequences for over-growth by pathogens such as Clostridium difficile. Annu Rev Microbiol 43: 69–87PubMedCrossRefGoogle Scholar
  14. 14.
    Marshall JC,Christou NV,Meakins JL (1993) The gastrointestinal tract. The “undrained abscess” of multiple organ failure. Ann Surg 218: 111–119PubMedCrossRefGoogle Scholar
  15. 15.
    Heyland DK, Cook DJ, Jaeschke R, Griffith L, Lee HN, Guyatt GH (1994) Selective decontamination of the digestive tract. An overview. Chest 105: 1221–1229PubMedCrossRefGoogle Scholar
  16. 16.
    Fagon J, Chastre J, Hance AJ, Domart Y, Trouillet J, Gibert C (1993) Evaluation of clinical judgment in the identification and treatment of nosocomial pneumonia in ventilated patients. Chest 103: 547–553PubMedCrossRefGoogle Scholar
  17. 17.
    Sterling TR, Ho EJ, Brehm WT, Kirkpatrick MB (1996) Diagnosis and treatment of ventilator- associated pneumonia — impact on survival. Chest 110: 1025–1034PubMedCrossRefGoogle Scholar
  18. 18.
    Timsit JF, Misset B, Renaud B, Goldstein FW, Carlet J (1997) Effect of previous antimicrobial therapy on the accuracy of the main procedures used to diagnose nosocomial pneumonia in patients who are using mechanical ventilation. Chest 108: 1036–1040CrossRefGoogle Scholar
  19. 19.
    Montravers P, Fagon JY, Chastre J, et al (1993) Follow-up protected specimen brushes to assess treatment in nosocomial pneumonia. Am Rev Respir Dis 147: 38–44PubMedCrossRefGoogle Scholar
  20. 20.
    Wunderink RG (1998) Attributable mortality of ventilator-associated pneumonia. Sepsis (In Press)Google Scholar
  21. 21.
    Thomas M, Govil S, Moses BV, Joseph A (1996) Monitoring of antibiotic use in a primary and tertiarry care hospital. J Clin Epidemiol 49: 251–254PubMedCrossRefGoogle Scholar
  22. 22.
    Torres A, Aznar R, Gatell JM, et al (1990) Incidence, risk and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis 142: 523–528PubMedCrossRefGoogle Scholar
  23. 23.
    Celis R, Torres A, Gatell JM, Almela M, Rodriguez-Roisin R, Agusti-Vidal A (1988) Nosocomial pneumonia. A multivariate analysis of risk and prognosis. Chest 93: 318–324PubMedCrossRefGoogle Scholar
  24. 24.
    Luna C, Vujacich P, Niederman MS, et al (1997) Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 111: 676–685PubMedCrossRefGoogle Scholar
  25. 25.
    Rello J, Ausina V, Ricart M, et al (1994) Risk factors for infection by Pseudomonas aeruginosa in patients with ventilator-associated pneumonia. Intensive Care Med 20: 193–198PubMedCrossRefGoogle Scholar
  26. 26.
    Kollef MH, Silver P, Murphy DM, Trovillion E (1995) The effect of late-onset ventilator-associated pneumonia in determining patient mortality. Chest 108: 1655–1662PubMedCrossRefGoogle Scholar
  27. 27.
    Rello J, Ausina V, Ricart M, Castella J, Prats G (1993) Impact of previous antimicrobial therapy on the etiology and outcome of ventilator associated pneumonia. Chest 104: 1230–1235PubMedCrossRefGoogle Scholar
  28. 28.
    Banerjee SN, Emori TG, Culver DH, et al (1997) Secular trends in nosocomial primary blood-stream infection in the United States, 1980–1989. National Nosocomial Infections Surveillance System. Am J Med 91 (suppl 3B): 86S–89SCrossRefGoogle Scholar
  29. 29.
    Valles J, Leon C, Alvarez-Lerma F (1997) Nosocomial bacteremia in critically ill patients: a multi- center study evaluating epidemiology and prognosis. Clin Infect Dis 24: 387–395PubMedCrossRefGoogle Scholar
  30. 30.
    Pittet D, Thievent B, Wenzel RP, Li N, Auckenthaler R, Suter PM (1996) Bedside prediction of mortality from bacteremic sepsis. A dynamic analysis of ICU patients. Am J Respir Crit Care Med 153: 684–693PubMedGoogle Scholar
  31. 31.
    Fagon JY, Novara A, Stephan F, Girou E, Safar M (1994) Mortality attributable to nosocomial infections in the ICU. Infect Control Hosp Epidemiol 15: 428–434PubMedCrossRefGoogle Scholar
  32. 32.
    Rello J, Ricart M, Mirelis B, et al (1994) Nosocomial bacteremia in a medical-surgical intensive care unit: epidemiologic characteristics and factors influencing mortality in 111 episodes. Intensive Care Med 20: 94–98PubMedCrossRefGoogle Scholar
  33. 33.
    Mainous MR, Lipsett PA, O’Brien M (1997) Enterococcal bacteremia in the surgical intensive care unit. Does vancomycin resistance affect mortality? Arch Surg 132: 76–81PubMedCrossRefGoogle Scholar
  34. 34.
    Nathens AB, Rotstein OD, Marshall JC (1998) Tertiary peritonitis: Clinical features of a complex nosocomial infection. World J Surg (In Press)Google Scholar
  35. 35.
    Bohnen JMA, Solomkin JS, Dellinger EP, Bjornson HS, Page CP (1992) Guidelines for clinical care: Anti-infective agents for intra-abdominal infection. A Surgical Infection Society policy statement. Arch Surg 127: 83–89PubMedCrossRefGoogle Scholar
  36. 36.
    Rotstein OD, Pruett TL, Simmons RL (1986) Microbiologic features and treatment of persistent peritonitis in patients in the intensive care unit. Can J Surg 29: 247–250PubMedGoogle Scholar
  37. 37.
    Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ (1995) Multiple organ dysfunction score: A reliable descriptor of a complex clinical outcome. Crit Care Med 23: 1638–1652PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1998

Authors and Affiliations

  • J. C. Marshall
  • D. C. Evans

There are no affiliations available

Personalised recommendations